In CRISPR Patent Dispute, the Federal Circuit Clarifies the Conception and Written Description Standards READ MORE
Settled Expectations: How the PTAB’s New Discretionary Denial Framework Is Reshaping IPR Strategy READ MORE
Regeneron Pharmaceuticals, Inc. v. Amgen Inc.: Jury Finds Rebate Offers on Bundled Drugs in Exchange for Exclusive Formulary Placement Violate Antitrust Laws READ MORE
Federal Circuit Provides Further Guidance on Obvious Type Double Patenting For Patents Sharing Common Priority READ MORE
The New York Intellectual Property Law Association (NYIPLA) announces its 2025-2026 Board of Directors. READ MORE
License to Exclude? Federal Circuit Emphasizes Need for Reliability of Patent Damages Experts in EcoFactor Inc. v. Google LLC READ MORE
Haug Partners Hosts Externs from the Reilly Program at the BOLD Center at Douglass College, Rutgers University READ MORE
